The Effects of Inhaled Airway Directed Pharmacotherapy on Decline in Lung Function Parameters Among Indigenous Australian Adults With and Without Underlying Airway Disease

References

• Leading causes of mortality. Australian Institute of Health and Welfare 2020. Aboriginal and Torres Strait Islander Health Performance Framework 2020 summary report. Cat. no. IHPF 2. Canberra: AIHW. Available from: https://www.indigenoushpf.gov.au/publications/hpf-summary-2020. Accessed July 5, 2021.
   Google Scholar
• Australian institute of health and welfare. Indigenous Australians more likely to die from CHD and COPD, but some positive trends emerging - Australian Institute of Health and Welfare; 2014. Available from: https://www.aihw.gov.au/news-media/media-releases/2014/june/indigenous-australians-more-likely-to-die-from-chd. Accessed July 5, 2021.
   Google Scholar
• Australian institute of health and welfare. Asthma. Cat. no. ACM 33. Canberra: AIHW; 2020. Available from: https://www.aihw.gov.au/reports/chronic-respiratory-conditions/asthma. Accessed July 5, 2021.
   Google Scholar
• Jenkins CR, Chang AB, Poulos LM, Marks GB. Asthma in Indigenous Australians: so much yet to do for Indigenous lung health. Med J Aust. 2009;190(10):530–531. doi:10.5694/j.1326-5377.2009.tb02550.x
   PubMed Web of Science ®Google Scholar
• Australian bureau of statistics. Estimates of Aboriginal and Torres Strait Islander Australians. Canberra, Australia: ABS; 2016.
   Google Scholar
• Australian bureau of statistics. Australian Statistical Geography Standard (ASGS): Volume 5—Remoteness Structure, July 2011. Canberra: Australian Bureau of Statistics; 2013.
   Google Scholar
• Heraganahally S, Wasgewatta SL, McNamara K, et al. Chronic obstructive pulmonary disease in Aboriginal patients of The Northern Territory of Australia: a landscape perspective. Int J Chron Obstruct Pulmon Dis. 2019;14:2205–2217. doi:10.2147/COPD.S213947
   PubMed Web of Science ®Google Scholar
• Kruavit A, Fox M, Pearson R, Heraganahally S. Chronic respiratory disease in the regional and remote population of the Northern Territory Top End: a perspective from the specialist respiratory outreach service. Aust J Rural Health. 2017;25:275–284. doi:10.1111/ajr.12349
   PubMed Web of Science ®Google Scholar
• Mehra S, Chang AB, Lam CK, et al. Bronchiectasis among Australian Aboriginal and Non-Aboriginal patients in the regional and remote population of the Northern Territory of Australia. Rural Remote Health. 2021;6390. doi:10.22605/RRH6390
   PubMed Web of Science ®Google Scholar
• Heraganahally SS, Silva SAMS, Howarth TM, Kangaharan N, Majoni SW. Comparison of clinical manifestation among Australian Indigenous and non‐ Indigenous patients presenting with pleural effusion. Int Med J. 2021. doi:10.1111/imj.15310
   Google Scholar
• Heraganahally SS, Mortimer N, Howarth T, et al. Utility and outcomes among Indigenous and non-Indigenous patients requiring domiciliary oxygen therapy in the regional and rural Australian population. Aust J Rural Health. 2021. doi:10.1111/ajr.12782
   PubMed Web of Science ®Google Scholar
• Heraganahally SS, Wasgewatta SL, McNamara K, et al. Chronic obstructive pulmonary disease with and without bronchiectasis in Aboriginal Australians – a comparative study. Int Med J. 2020;50(12):1505–1513. doi:10.1111/imj.14718
   Google Scholar
• Schubert J, Kruavit A, Mehra S, Wasgewatta S, Chang AB, Heraganahally S. Prevalence and nature of lung function abnormalities among Indigenous Australians referred to specialist respiratory outreach clinics in the Northern Territory. Int Med J. 2019;49:217–224. doi:10.1111/imj.14112
   Google Scholar
• Heraganahally SS, Howarth T, White E, Sorger L, Biancardi E, Ben Saad H. Lung function parameters among Australian Aboriginal “apparently healthy” adults: an Australian Caucasian and global lung function initiative (GLI-2012) various ethnic norms comparative study. Expert Rev Respir Med. 2020;23:1–11. doi:10.1080/17476348.2021.1847649
   Web of Science ®Google Scholar
• Howarth TP, Saad HB, Perez AJ, Atos CB, White E, Heraganahally SS. Comparison of diffusing capacity of carbon monoxide (DLCO) and total lung capacity (TLC) between Indigenous Australians and Australian Caucasian adults. PLoS One. 2021;16(4):e0248900. doi:10.1371/journal.pone.0248900
   PubMed Web of Science ®Google Scholar
• Heraganahally SS, Howarth T, Mo L, Sorger L, Saad HB. Critical analysis of spirometric patterns in correlation to chest computed tomography among adult Indigenous Australians with chronic airway diseases. Expert Rev Respir Med. 2021;15(9):1229–1238. doi:10.1080/17476348.2021.1928496
   PubMed Web of Science ®Google Scholar
• Johnson JD, Theurer WH. A stepwise approach to the interpretation of pulmonary function tests. Am Fam Physician. 2014;89(5):359–366.
   PubMed Web of Science ®Google Scholar
• Ranu H, Wilde M, Madden B. Pulmonary function tests. Ulster Med J. 2011;80(2):84–90.
   PubMedGoogle Scholar
• Liang BM, Lam DC, Feng YL. Clinical applications of lung function tests: a revisit. Respirology. 2012;17(4):611–619. doi:10.1111/j.1440-1843.2012.02149.x
   PubMed Web of Science ®Google Scholar
• Ostrowski S, Bilan A. The natural history of respiratory system function. J Physiol Pharmacol. 2004;55(Suppl 3):95–100.
   PubMedGoogle Scholar
• Van Oostrom SH, Engelfriet PM, Verschuren WMM, et al. Aging-related trajectories of lung function in the general population—The Doetinchem Cohort Study. PLoS One. 2018;13(5):e0197250. doi:10.1371/journal
   PubMed Web of Science ®Google Scholar
• Lak VWM, Skoog I, Guo X. Secular trends in lung function and its relation to survival in Swedish 75 year olds 1976–2006. Age Ageing. 2012;41:735–740. doi:10.1093/ageing/afs098
   PubMed Web of Science ®Google Scholar
• Fletcher C, Peto R. The natural history of chronic airflow obstruction. Br Med J. 1977;1(6077):1645–1648. doi:10.1136/bmj.1.6077.1645
   PubMed Web of Science ®Google Scholar
• Sears MR. Lung function decline in asthma. Eur Respir J. 2007;30(3):411–413. doi:10.1183/09031936.00080007
   PubMed Web of Science ®Google Scholar
• Leem AY, Park B, Kim YS, Chang J, Won S, Jung JY. Longitudinal decline in lung function: a community-based cohort study in Korea. Sci Rep. 2019;9:13614. doi:10.1038/s41598-019-49598-9
   PubMed Web of Science ®Google Scholar
• Tantucci C, Modina D. Lung function decline in COPD. Int J Chron Obstruct Pulmon Dis. 2012;7:95–99. doi:10.2147/COPD.S27480
   PubMed Web of Science ®Google Scholar
• Martínez-García MA, Soler-Cataluña JJ, Perpiñá-Tordera M, Román-Sánchez P, Soriano J. Factors associated with lung function decline in adult patients with stable non-cystic fibrosis bronchiectasis. Chest. 2007;132:1565–1572. doi:10.1378/chest.07-0490
   PubMed Web of Science ®Google Scholar
• Dijkstra A, Vonk JM, Jongepier H, et al. Lung function decline in asthma: association with inhaled corticosteroids, smoking and sex. Thorax. 2006;61(2):105–110. doi:10.1136/thx.2004.039271
   PubMed Web of Science ®Google Scholar
• Borghardt JM, Kloft C, Sharma A. Inhaled therapy in respiratory disease: the complex interplay of pulmonary kinetic processes. Can Respir J. 2018;19:2732017. doi:10.1155/2018/2732017
   Web of Science ®Google Scholar
• Usmani OS. Treating the small airways. Respiration. 2012;84:441–453. doi:10.1159/000343629
   PubMed Web of Science ®Google Scholar
• Almeida PCA, Ponte EV, Souza-Machado A, Cruz AA. Longitudinal trends in clinical characteristics and lung function of patients with severe asthma under treatment in Brazil. BMC Pulm Med. 2016;16:141. doi:10.1186/s12890-016-0302-5
   PubMed Web of Science ®Google Scholar
• Park HY, Lee SY, Kang D, et al. Favorable longitudinal change of lung function in patients with asthma-COPD overlap from a COPD cohort. Respir Res. 2018;19(1):36. doi:10.1186/s12931-018-0737-8
   PubMed Web of Science ®Google Scholar
• Lange P, Scharling H, Ulrik CS, Vestbo J. Inhaled corticosteroids and decline of lung function in community residents with asthma. Thorax. 2006;61(2):100–104. doi:10.1136/thx.2004.037978
   PubMed Web of Science ®Google Scholar
• Suissa S. Medications to modify lung function decline in chronic obstructive pulmonary disease: some hopeful signs. Am J Respir Crit Care Med. 2008;178(4):322–323. doi:10.1164/rccm.200805-721ED
   PubMed Web of Science ®Google Scholar
• Soriano JB, Sin DD, Zhang X, et al. A pooled analysis of FEV1 decline in COPD patients randomized to inhaled corticosteroids or placebo. Chest. 2007;131(3):682–689. doi:10.1378/chest.06-1696
   PubMed Web of Science ®Google Scholar
• Tashkin DP, Strange C. Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy? Int J Chron Obstruct Pulmon Dis. 2018;13:2587–2601. doi:10.2147/COPD.S172240
   PubMed Web of Science ®Google Scholar
• Huria T, Palmer SC, Pitama S, et al. Consolidated criteria for strengthening reporting of health research involving indigenous peoples: the CONSIDER statement. BMC Med Res Methodol. 2019;19:173. doi:10.1186/s12874-019-0815-8
   PubMed Web of Science ®Google Scholar
• Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319–338. doi:10.1183/09031936.05.00034805
   PubMed Web of Science ®Google Scholar
• NDD Medical Technologies. EasyOne Pro®; 2017. Available from: https://www.ndd.ch/en/product/easyone-pro.html. Accessed September 16, 2021.
   Google Scholar
• Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med. 1999;159(1):179–187. doi:10.1164/ajrccm.159.1.9712108
   PubMed Web of Science ®Google Scholar
• Cooksley NA, Atkinson D, Marks GB, et al. Prevalence of airflow obstruction and reduced forced vital capacity in an Aboriginal Australian population: the cross‐sectional BOLD study. Respirology. 2015;20:766–774. doi:10.1111/resp.12482
   PubMed Web of Science ®Google Scholar
• Global initiative for chronic obstructive lung disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Available from: http://www.goldcopd.org. Accessed September 16, 2021.
   Google Scholar
• Redlich CA, Tarlo SM, Hankinson JL, et al. Official American thoracic society technical standards: spirometry in the occupational setting. Am J Respir Crit Care Med. 2014;189(8):984–994. doi:10.1164/rccm.201402-0337ST
   Web of Science ®Google Scholar
• State of the world’s Indigenous peoples. Indigenous peoples’ access to health services. United nations; 2018. Available from: https://www.un.org/development/desa/indigenouspeoples/wp-content/uploads/sites/19/2018/03/The-State-of-The-Worlds-Indigenous-Peoples-WEB.pdf. Accessed September 16, 2021.
   Google Scholar
• GBD 2016 Healthcare access and quality collaborators. Measuring performance on the healthcare access and quality index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016. Lancet. 2018;391:2236–2271.
   PubMed Web of Science ®Google Scholar
• Ospina MB, Voaklander DC, Stickland MK. Prevalence of asthma and chronic obstructive pulmonary disease in Aboriginal and non-Aboriginal populations: a systematic review and meta-analysis of epidemiological studies. Can Respir J. 2012;19(6):355–360. doi:10.1155/2012/825107
   PubMed Web of Science ®Google Scholar
• Celli BR, Anderson JA, Cowans NJ. Pharmacotherapy and lung function decline in patients with chronic obstructive pulmonary disease. A systematic review. Am J Respir Crit Care Med. 2021;203(6):689–698. doi:10.1164/rccm.202005-1854OC
   PubMed Web of Science ®Google Scholar
• Koarai A, Sugiura H, Yamada M, et al. Treatment with LABA versus LAMA for stable COPD: a systematic review and meta-analysis. BMC Pulm Med. 2020;20:111. doi:10.1186/s12890-020-1152-8
   PubMed Web of Science ®Google Scholar
• Suissa S. Inhaled corticosteroids preventing pneumonia mortality: paradox or selection bias? Eur Respir J. 2019;53:1802112. doi:10.1183/13993003.02112-2018
   PubMed Web of Science ®Google Scholar
• Woodhead M. Inhaled corticosteroids cause pneumonia … or do they? Am J Respir Crit Care Med. 2007;176(2):111–112. doi:10.1164/rccm.200703-492ED
   PubMed Web of Science ®Google Scholar
• Lopez-Campos JL, Miravitlles M, de la Rosa Carrillo D, Cantón R, Soler-Cataluña JJ, Martinez-Garcia MA. Current challenges in chronic bronchial infection in patients with chronic obstructive pulmonary disease. J Clin Med. 2020;9(6):1639. doi:10.3390/jcm9061639
   PubMed Web of Science ®Google Scholar
• Sibila O, Soto-Gomez N, Restrepo MI. The risk and outcomes of pneumonia in patients on inhaled corticosteroids. Pulm Pharmacol Ther. 2015;32:130–136. doi:10.1016/j.pupt.2015.04.001
   PubMed Web of Science ®Google Scholar
• Tashkin DP, Miravitlles M, Celli BR, et al. Concomitant inhaled corticosteroid use and the risk of pneumonia in COPD: a matched-subgroup post hoc analysis of the UPLIFT® trial. Respir Res. 2018;19(1):196. doi:10.1186/s12931-018-0874-0
   PubMedGoogle Scholar
• Heraganahally SS, Ghataura AS, Er XY, Heraganahally S, Biancardi E. Excessive dynamic airway collapse: a COPD/Asthma mimic or a treatment emergent consequence of inhaled corticosteroid therapy - case series and brief literature review. Clin Pulm Med. 2020;27:175–182. doi:10.1097/CPM.0000000000000382
   Google Scholar
• Kapur N, Petsky HL, Bell S, Kolbe J, Chang AB. Inhaled corticosteroids for bronchiectasis. Cochrane Database Syst Rev. 2018;16(5):CD000996. doi:10.1002/14651858.CD000996.pub3
   Web of Science ®Google Scholar
• Henkle E, Curtis JR, Chen L, et al. Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasis. Eur Respir J. 2019;54(1):1801896. doi:10.1183/13993003.01896-2018
   PubMed Web of Science ®Google Scholar
• Pasteur MC, Bilton D. British thoracic society guideline for non-CF bronchiectasis on behalf of the British thoracic society bronchiectasis (non-CF) guideline group. Thorax. 2010;65:i1ei58. doi:10.1136/thx.2010.136119
   Google Scholar
• Jeong HJ, Lee H, Carriere KC, et al. Effects of long-term bronchodilators in bronchiectasis patients with airflow limitation based on bronchodilator response at baseline. Int J Chron Obstruct Pulmon Dis. 2016;11:2757–2764. doi:10.2147/COPD.S115581
   PubMed Web of Science ®Google Scholar
• Chalmers JD, Aliberti S, Blasi F. Management of bronchiectasis in adults. Eur Respir J. 2015;45:1446–1462. doi:10.1183/09031936.00119114
   PubMed Web of Science ®Google Scholar
• Whittaker HR, Jarvis D, Sheikh MR, Kiddle SJ, Quint JK. Inhaled corticosteroids and FEV1 decline in chronic obstructive pulmonary disease: a systematic review. Respir Res. 2019;20:277. doi:10.1186/s12931-019-1249-x
   PubMed Web of Science ®Google Scholar
• Snoeck-Stroband JB, Lapperre TS, Sterk PJ, GLUCOLD Study Group. Prediction of long-term benefits of inhaled steroids by phenotypic markers in moderate-to-severe COPD: a randomized controlled trial. PLoS One. 2015;10(12):e0143793. doi:10.1371/journal.pone.0143793
   PubMed Web of Science ®Google Scholar
• Lange P, Celli B, Agustí A, et al. Lung-function trajectories leading to chronic obstructive pulmonary disease. N Engl J Med. 2015;373:111–122. doi:10.1056/NEJMoa1411532
   PubMed Web of Science ®Google Scholar
• Murray R. Prescribing issues for Aboriginal people. Aust Prescr. 2003;26:55–57. doi:10.18773/austprescr.2003.080
   Google Scholar
• Agusti A, Fabbri LM, Singh D, et al. Inhaled corticosteroids in COPD: friend or foe? Eur Respir J. 2018;52:1801219. doi:10.1183/13993003.01219-2018
   PubMed Web of Science ®Google Scholar
• Heraganahally SS, Rajaratnam B, Silva SAAS, et al. Obstructive sleep apnoea and cardiac disease among Aboriginal patients in the Northern Territory of Australia. Heart Lung Circ. 2021. doi:10.1016/j.hlc.2021.01.007
   PubMed Web of Science ®Google Scholar
• Heraganahally SS, Kruavit A, Oguoma VM, et al. Sleep apnoea among Australian Aboriginal and Non- Aboriginal patients in the Northern Territory of Australia– a comparative study. Sleep. 2020;43(3):zsz248. doi:10.1093/sleep/zsz248
   PubMed Web of Science ®Google Scholar
• Mehra S, Ghimire RH, Mingi JJ, et al. Gender differences in the clinical and polysomnographic characteristics among Australian Aboriginal patients with obstructive sleep apnea. Nat Sci Sleep. 2020;12:593–602. doi:10.2147/NSS.S258330
   PubMed Web of Science ®Google Scholar
• Heraganahally SS, Kerslake C, Issac S, et al. Outcome of public hospital-funded continuous positive airway therapy device for patients with obstructive sleep apnoea: an Australian perspective study. Sleep Vigilance. 2020;4:195–204. doi:10.1007/s41782-020-00114-4
   Google Scholar
• Heraganahally SS, Zaw KK, Tip S, et al. Obstructive sleep apnoea and adherence to continuous positive airway therapy among Australian women. Int Med J. 2020. doi:10.1111/imj.15076
   Google Scholar
• Garg H, Er XY, Howarth T, Heraganahally SS. Positional Sleep apnea among regional and remote Australian population and simulated positional treatment effects. Nat Sci Sleep. 2020;12:1123–1135. doi:10.2147/NSS.S286403
   PubMed Web of Science ®Google Scholar
• Benn E, Wirth H, Short T, Howarth T, Heraganahally SS. The Top End sleepiness scale (TESS): a new tool to assess subjective daytime sleepiness among Indigenous Australian adults. Nat Sci Sleep. 2021;13:315–328. doi:10.2147/NSS.S298409
   PubMed Web of Science ®Google Scholar
• Heraganahally SS, Howarth TP, Sorger L. Chest computed tomography findings among adult Indigenous Australians in the Northern Territory of Australia. J Med Imaging Radiat Oncol. 2021. doi:10.1111/1754-9485.13295
   PubMed Web of Science ®Google Scholar
• Koleade A, Farrell J, Mugford G, Gao Z. Prevalence and risk factors of ACO (Asthma-COPD Overlap) in Aboriginal people. J Environ Public Health. 2018;9. doi:10.1155/2018/4657420
   Web of Science ®Google Scholar
• Contolihttps M, Morandia L, Marcob FD, Caronec M. A perspective for chronic obstructive pulmonary disease (COPD) management: six key clinical questions to improve disease treatment. Expert Opin Pharmacother. 2021;22(4):427–437. doi:10.1080/14656566.2020.1828352
   PubMed Web of Science ®Google Scholar
• Vimala LR, Gibikote S, Christopher DJ, Irodi A, Rajan M, Ramasami P. Correlation of digital chest radiograph parameters with pulmonary function test and BODE index for diagnosis and prognostication in Indian COPD patients. J Lung Pulmonary Respir Res. 2018;5(1):584. doi:10.15406/jlprr.2018.05.00154
   Google Scholar